Merck & Co. Inc., known as MSD outside the United States and Canada, will host a virtual investor event on July 17, 2025, at 9:00 a.m. ET. During this event, Merck's scientific and commercial team leaders will present an overview of the company's advancing research pipeline for HIV treatment and prevention.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250624824330) on June 24, 2025, and is solely responsible for the information contained therein.